Patients are unlikely to find a local ophthalmic practice utilizing technology as extensively or effectively as our practice, where diagnostic tools are fundamental to a comprehensive assessment.
Some of the advanced diagnostic tools we use include:
IProfiler: a scanning laser topographer and wavefront abberometer that accurately maps the corneal surface and the optical fingerprint of the eye. The result is a more precise prescription and enhanced vision.
Retinal Camera: an instrument used to detect and manage potentially sight-threatening diseases such as glaucoma, diabetes, hypertension, and macular degeneration. Retinal imaging also provides a baseline that can be used to compare retinal health from year to year. For some aspects of disease such as diabetes or glaucoma it can be more accurate at identifying eye disease.
Specular Microscope: a powerful instrument used to identify, measure, and assess cell loss and damage that occurs over time. This is an invaluable tool used to identify subtle damage caused by the overuse or improper fitting of contact lenses. It is also used to identify low cell counts prior to cataract surgery or retinal surgery. Over 60% of the power of the eye is due to the cornea. It is the major refracting component and there is no comparable to assess corneal health.
OCT: a high-speed, high-resolution laser scanner used to detect retinal disease including macular degeneration, macular edema, and epi-retinal membranes. It also scans the optic nerve, the nerve fiber layer, and the ganglion cell layer. With five micron resolution and normative data profiling it can identify when we need to treat or monitor eye disease. It can also scan the anterior cornea for penetrating foreign bodies, thin corneas and patients at risk of angle closure glaucoma.
I-terminal: a precision digital camera and computerized measuring system used to prescribe the most accurate lenses in the world. The camera measures to within 1.mm where we place the optics in your glasses.
I-Care Tonometer: a safe, non-invasive tool used to measure intraocular pressure; something that can damage the optic nerve and lead to glaucoma.
Fields: we are always updating our field technology. Newer technology allows us more sensitive identification of early loss such as frequency doubling technology, improved specificity for specific field loss such as central loss for glaucoma or glaucoma specific protocols and lastly progression analysis. Having the latest progression software allows us to identify early changes and intervene for patient undergoing treatment.
Tearlab Osmolarity: a new FDA approved in-office method of analyzing tear osmolarity. In the clinical presentation of dry eye osmolarity increases as the eye becomes more dry. This new test allows us to quantify clinically significant dry eye and ensure our treatment is showing improvement.
Lipiview & Lipiflow: analyzing over 1 billion corneal images lipiview allows us to measure the tear oil density. This is used in the differential diagnosis of dry eye. There are two basic types of dry eye; evaporative (not enough oil) and aqueous deficient (not enough tears). Studies show us that 85% of patients are evaporative. Not only can we diagnose better but we can now treat the glands (called meibomian glands) responsible for dry eye and in the process better address the dry eye.
Sjogren’s Disease SJO: Sjogren’s disease is an auto-immune disease where white blood cells attack the mucous membranes of the body. There are 2.5x more Sjjogren’s patients that patients with Rheumatoid Arthritis and 75% of them are not diagnosed. This in part due to extensive lab work required and painful biopsies. A new test by Nicox is available to CLIA approved practices (we are one) that tests 13 different biomarkers and allows a 90-95% accuracy of diagnosing Sjogren’s. It is estimated that one in 10 dry eye patients have undiagnosed Sjogren’s disease.
ColorDx: It is only until recently that clinical testing of acquired color defects has been available. The cones responsible for our color vision and not surprisingly they are very sensitive to changes in diseases like glaucoma and macular degeneration. In fact research has shown us that color vision more commonly precede changes in structure (OCT) and function (visual acuity or visual field) in macular degeneration and glaucoma. Being able to not only test but analyze threshold color sensitivity for comparative changes allows us to identify early changes in many diseases in including macular degeneration and glaucoma.
Learn about What to Expect at your visit.